HYLG


Health Care Covered Call & Growth ETF

Reasons to Consider HYLG

High Income Potential

HYLG seeks to generate income by writing covered calls on the Health Care Select Sector SPDR Fund.

Upside Potential

By writing calls on 50% of the Health Care Select Sector SPDR Fund, the strategy allows investors to capture half the upside potential of the Health Care Select Sector Index.

Monthly Distributions

HYLG seeks to make distributions on a monthly basis.

Key Information As of 11/28/22

Inception Date 11/21/22
Gross Expense Ratio 0.66%
Net Expense Ratio* 0.60%
Net Assets $2.53 million
NAV $25.26
Fact Sheet

*Fee waivers are contractual and in effect until at least March 1, 2024.


ETF Summary

The Global X Health Care Covered Call & Growth ETF (HYLG) follows a “covered call” or “buy-write” strategy, in which the Fund buys the stocks in the Health Care Select Sector Index and the Health Care Select Sector SPDR Fund, and “writes” or “sells” corresponding call options on the Health Care Select Sector SPDR Fund representing approximately 50% of the value of HYLG’s portfolio.

ETF Objective

The Global X Health Care Covered Call & Growth ETF (HYLG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P Health Care Select Sector Half BuyWrite Index.

Trading Details As of 11/28/22

Ticker HYLG
Bloomberg Index Ticker BXLVH
CUSIP 37960A750
ISIN US37960A7506
Primary Exchange NYSE Arca
Shares Outstanding 100,000
Number of Holdings 66
30-Day Median Bid-Ask Spread N/A

Distributions As of 11/28/22

30-Day SEC Yield N/A
Unsubsidized 30-Day SEC Yield N/A
Distribution Frequency Monthly

ETF Prices As of 11/28/22

NAV $25.26 Daily Change -$0.15 -0.57%
Market Price $25.28 Daily Change -$0.11 -0.44%

Performance History

As of recent
(09/30/22)
Fund NAV Market Price Index
Year-to-Date -- -- --
1 Month -- -- --
3 Months -- -- --
Since Inception -- -- --
Year-to-Date -- -- --
1 Month -- -- --
3 Months -- -- --
Since Inception -- -- --

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 11/28/22

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
55.98 XLV HEALTH CARE SELECT SECTOR 2371823 136.12 10,387 1,413,878.44
4.43 UNH UNITEDHEALTH GROUP INC 2917766 532.27 210 111,776.70
4.14 JNJ JOHNSON & JOHNSON 2475833 177.33 590 104,624.70
2.61 LLY ELI LILLY & CO 2516152 365.77 180 65,838.60
2.50 ABBV ABBVIE INC B92SR70 158.43 399 63,213.57
2.45 PFE PFIZER INC 2684703 49.57 1,250 61,962.50
2.45 MRK MERCK & CO. INC. 2778844 108.45 570 61,816.50
1.92 TMO THERMO FISHER 2886907 540.03 90 48,602.70
1.63 ABT ABBOTT LABORATORIES 2002305 105.39 390 41,102.10
1.55 DHR DANAHER CORP 2250870 261.16 150 39,174.00
1.50 BMY BRISTOL-MYERS SQUIBB CO 2126335 79.14 480 37,987.20
1.34 AMGN AMGEN INC 2023607 282.62 120 33,914.40
1.15 CVS CVS HEALTH CORP 2577609 100.41 290 29,118.90
1.10 ELV ELEVANCE HEALTH INC BSPHGL4 512.78 54 27,690.12
0.95 GILD GILEAD SCIENCES INC 2369174 85.21 280 23,858.80
0.90 MDT MEDTRONIC PLC BTN1Y11 76.13 300 22,839.00
0.89 CI CIGNA CORP BHJ0775 319.51 70 22,365.70
0.83 ISRG INTUITIVE SURGICAL INC 2871301 262.64 80 21,011.20
0.75 VRTX VERTEX PHARM 2931034 315.30 60 18,918.00
0.72 SYK STRYKER CORP 2853688 227.27 80 18,181.60
0.71 REGN REGENERON PHARMACEUTICALS 2730190 741.48 24 17,795.52
0.64 HUM HUMANA INC 2445063 534.29 30 16,028.70
0.59 ZTS ZOETIS INC B95WG16 148.13 100 14,813.00
0.56 BDX BECTON DICKINSON AND CO 2087807 237.34 60 14,240.40
0.56 MRNA MODERNA INC BGSXTS3 175.38 80 14,030.40
0.56 BSX BOSTON SCIENTIFIC CORP 2113434 43.79 320 14,012.80
0.46 HCA HCA HEALTHCARE INC B4MGBG6 234.35 50 11,717.50
0.45 MCK MCKESSON CORP 2378534 380.34 30 11,410.20
0.44 CNC CENTENE CORP 2807061 84.93 130 11,040.90
0.42 A AGILENT TECHNOLOGIES INC 2520153 152.30 70 10,661.00
0.42 EW EDWARDS LIFESCIENCES CORP 2567116 75.78 140 10,609.20
0.40 DXCM DEXCOM INC B0796X4 112.57 90 10,131.30
0.35 BIIB BIOGEN INC 2455965 291.90 30 8,757.00
0.34 ILMN ILLUMINA INC 2613990 216.91 40 8,676.40
0.34 IQV IQVIA HOLDINGS INC BDR73G1 214.45 40 8,578.00
0.32 IDXX IDEXX LABORATORIES INC 2459202 400.10 20 8,002.00
0.29 MTD METTLER-TOLEDO 2126249 1,439.89 5 7,199.45
0.27 RMD RESMED INC 2732903 225.54 30 6,766.20
0.27 ABC AMERISOURCEBERGEN CORP 2795393 167.17 40 6,686.80
0.24 BAX BAXTER INTERNATIONAL INC 2085102 55.19 110 6,070.90
0.23 ZBH ZIMMER BIOMET HO 2783815 117.67 50 5,883.50
0.19 LH LABORATORY CP 2586122 238.36 20 4,767.20
0.19 CAH CARDINAL HEALTH INC 2175672 78.46 60 4,707.60
0.18 WST WEST PHARMACEUT 2950482 224.18 20 4,483.60
0.18 DGX QUEST DIAGNOSTICS INC 2702791 149.07 30 4,472.10
0.18 HOLX HOLOGIC INC 2433530 73.85 60 4,431.00
0.16 PKI PERKINELMER INC 2305844 133.68 30 4,010.40
0.15 ALGN ALIGN TECHNOLOGY INC 2679204 189.78 20 3,795.60
0.15 ABMD ABIOMED INC 2003698 377.23 10 3,772.30
0.14 STE STERIS PLC BFY8C75 178.24 20 3,564.80
0.14 CASH 1.00 3,475 3,474.96
0.13 WAT WATERS CORP 2937689 331.60 10 3,316.00
0.13 TECH BIO-TECHNE CORP BSHZ3Q0 330.40 10 3,304.00
0.13 MOH MOLINA HEALTHCARE INC 2212706 326.53 10 3,265.30
0.12 INCY INCYTE CORP 2471950 77.83 40 3,113.20
0.12 COO COOPER COS INC/THE 2222631 308.33 10 3,083.30
0.12 VTRS VIATRIS INC BMWS3X9 11.06 270 2,986.20
0.10 HSIC HENRY SCHEIN INC 2416962 80.28 30 2,408.40
0.09 CRL CHARLES RIVER LA 2604336 237.11 10 2,371.10
0.09 TFX TELEFLEX INC 2881407 224.49 10 2,244.90
0.08 BIO BIO-RAD LABORATORIES-A 2098508 398.41 5 1,992.05
0.07 CTLT CATALENT INC BP96PQ4 46.92 40 1,876.80
0.06 XRAY DENTSPLY SIRONA INC BYNPPC6 30.46 50 1,523.00
0.06 OGN ORGANON & CO BLDC8J4 24.66 60 1,479.60
0.05 UHS UNIVERSAL HLTH-B 2923785 129.13 10 1,291.30
0.03 DVA DAVITA INC 2898087 72.08 10 720.80
-1.66 XLV US 12/16/2022 C133 445.40 -94 -41,867.39
Holdings are subject to change.

ETF Research

Investing involves risk, including the possible loss of principal. Concentration in a particular industry or sector will subject HYLG to loss due to adverse occurrences that may affect that industry or sector. Investors in HYLG should be willing to accept a high degree of volatility in the price of the fund’s shares and the possibility of significant losses. The health care industry could be adversely affected by various political, regulatory, supply-and-demand, and other economic factors.

HYLG engages in options trading. An option is a contract sold by one party to another that gives the buyer the right, but not the obligation, to buy (call) or sell (put) a stock at an agreed upon price within a certain period or on a specific date. A covered call option involves holding a long position in a particular asset, in this case U.S. common equities, and writing a call option on that same asset with the goal of realizing additional income from the option premium. By selling covered call options, the fund limits its opportunity to profit from an increase in the price of the underlying index above the exercise price, but continues to bear the risk of a decline in the index. A liquid market may not exist for options held by the fund. While the fund receives premiums for writing the call options, the price it realizes from the exercise of an option could be substantially below the indices current market price. HYLG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. The market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share, and do not represent the returns you would receive if you traded shares at other times. NAVs are calculated using prices as of 4:00 PM Eastern Time. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Cboe, nor does Cboe make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Cboe.

Back to Top